|
Jan 5
|
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
|
|
Jan 4
|
Why Novo Nordisk Stock Crushed the Market Today
|
|
Jan 4
|
Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
|
|
Jan 4
|
Novo Nordisk enters research partnerships with biotech firms
|
|
Jan 4
|
The Best Stocks to Invest $1,000 in Right Now
|
|
Jan 4
|
Here's Why You Should Invest in Adverum (ADVM) Stock Now
|
|
Jan 4
|
Novo Signs $1.1 Billion Obesity R&D Deals With Two Biotechs
|
|
Jan 4
|
Wegovy maker Novo Nordisk enters research tie-ups with US biotech firms
|
|
Jan 4
|
Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
|
|
Jan 2
|
YEARENDER-Weight-loss drugs: Who, and what, are they good for?
|
|
Jan 2
|
EXPLAINER-What other health conditions might weight-loss drugs treat?
|
|
Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
|
Dec 30
|
Ozempic drugmaker to open AI research hub in King’s Cross
|
|
Dec 30
|
14 Money Making Stocks To Invest In
|
|
Dec 29
|
Neurological and obesity drugs will be prevalent in 2024
|
|
Dec 28
|
The Zacks Analyst Blog Highlights Novo Nordisk, Walmart, Advanced Micro Devices, Caterpillar and Union Pacific
|
|
Dec 28
|
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
|
|
Dec 28
|
Novo Nordisk (NVO) Rose on Increased Demand
|
|
Dec 27
|
Top Analyst Reports for Novo Nordisk, Walmart & AMD
|
|
Dec 27
|
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024
|